BioLife Solutions, Inc. (BLFS) vs Generate Biomedicines, Inc. (GENB)

A side-by-side comparison of BioLife Solutions, Inc. and Generate Biomedicines, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
BioLife Solutions, Inc. logo
BLFS
BioLife Solutions, Inc.
$1.89B
$38.61HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Generate Biomedicines, Inc. logo
GENB
Generate Biomedicines, Inc.
$1.75B
$13.64HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT

Total return — BLFS vs GENB

growth of $100 · dividends reinvested · last 1y
BLFS +71.8% (+71.8%/yr)GENB +10.0% (+10.0%/yr)BLFS compounded faster over this window
80100120140160Start $100$172$110
BLFS GENB

BLFS vs GENB: by the numbers

  • •BLFS is the larger company ($1.89B vs $1.75B market cap).
  • •BLFS is profitable (49.06% net margin) while GENB runs a net loss (-636.99%).

Metrics side by side

Valuation

MetricBLFSGENB
P/E ratio37.72N/A
Forward P/E64.35N/A
P/S ratio18.35N/A
P/B ratio4.493.83
EV / EBITDA170.26N/A

Profitability

MetricBLFSGENB
Gross margin64.48%100.00%
Operating margin-1.12%-737.04%
Net margin49.06%-636.99%
ROE12.01%N/A
ROIC1.72%-94.79%

Growth (annualized)

MetricBLFSGENB
Revenue CAGR (5Y)6.78%N/A
Total return CAGR (5Y)-0.77%N/A

Frequently asked

Is BLFS or GENB more profitable?
BLFS runs the higher net margin — BLFS at 49.06% versus GENB at -636.99%.

Go deeper

Full BLFS analysisFull GENB analysisInteractive comparison tool

Dig into the metrics

BioLife Solutions P/E ratioBioLife Solutions ROEGenerate Biomedicines ROEBioLife Solutions operating marginGenerate Biomedicines operating marginBioLife Solutions revenue growthGenerate Biomedicines revenue growthBioLife Solutions free cash flowGenerate Biomedicines free cash flow

BioLife Solutions & Generate Biomedicines appear in these rankings

Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.